Company profile
Lys Therapeutics
First-in-class biotherapies against neurological diseases. Targeting neuroinflammation to tackle neurodegeneration.
- Industry
- Biotechnology Research
- Employees
- 15
- Headquarters
- Lyon, Auvergne-Rhône-Alpes
- Founded
- 2021
- LinkedIn followers
- 4,097
- Office locations
- 2
Lys Therapeutics company summary
Lys Therapeutics is a company in the Biotechnology Research industry, headquartered in Lyon, Auvergne-Rhône-Alpes, founded in 2021. On LinkedIn the company has around 15 employees and 4,097 followers. The company lists 2 office locations. Its listed specialties include Stroke, Multiple Sclerosis, Neurology, Neurodegenerative disorders, Healthcare.
What technology does Lys Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Lys Therapeutics
Lys Therapeutics is a biotechnology company developing first-in-class monoclonal antibodies to treat patients suffering from neurodegenerative and neurovascular diseases with high unmet medical needs. Its lead candidate, LYS241, is a vascular-targeting immunotherapy with a unique mode of action counteracting neuroinflammation & BBB disruption by blocking the pathological interaction between tPA and NMDA receptors. This mechanism is central to the pathogenesis of several major neurological disorders, including Parkinson’s disease, multiple system atrophy, ischemic stroke, and other neuro-inflammatory conditions. With operations in Lyon and Caen (France), and strategic collaborations with international research institutions, Lys Therapeutics is advancing a robust and versatile pipeline, supported by prestigious funding partners including The Michael J. Fox Foundation, Bpifrance, and private investors. Lys Therapeutics' approach of targeting neuroinflammation to combat neurodegeneration represents a promising avenue in the search for effective treatments for these debilitating disorders. More information on lystherapeutics.com
Specialties
Where is Lys Therapeutics located?
Lys Therapeutics lists 2 office locations.
Compare companies similar to Lys Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Lys Therapeutics lystherapeutics.com | Biotechnology Research | 15 | 2021 | Lyon, Auvergne-Rhône-Alpes |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Lys Therapeutics
What does Lys Therapeutics do?
Lys Therapeutics is a biotechnology company developing first-in-class monoclonal antibodies to treat patients suffering from neurodegenerative and neurovascular diseases with high unmet medical needs. Its lead candidate, LYS241, is a vascular-targeting immunotherapy with a unique mode of action counteracting neuroinflammation & BBB disruption by blocking the pathological interaction between tPA and NMDA receptors. This mechanism is central to the pathogenesis of several major neurological disorders, including Parkinson’s disease, multiple system atrophy, ischemic stroke, and other neuro-inflammatory conditions. With operations in Lyon and Caen (France), and strategic collaborations with international research institutions, Lys Therapeutics is advancing a robust and versatile pipeline, supported by prestigious funding partners including The Michael J. Fox Foundation, Bpifrance, and private investors. Lys Therapeutics' approach of targeting neuroinflammation to combat neurodegeneration represents a promising avenue in the search for effective treatments for these debilitating disorders. More information on lystherapeutics.com
How many employees does Lys Therapeutics have?
Lys Therapeutics has around 15 employees on LinkedIn.
Where is Lys Therapeutics headquartered?
Lys Therapeutics is headquartered in Lyon, Auvergne-Rhône-Alpes.
Where does Lys Therapeutics have offices?
Lys Therapeutics lists 2 office locations, including Lyon, Auvergne-Rhône-Alpes, FR; Caen, Normandy, FR.
When was Lys Therapeutics founded?
Lys Therapeutics was founded in 2021.
Build a lead list from companies like Lys Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.